Preliminary data from researchers at the University of Cincinnati Cancer Center show that immunotherapy doesn’t necessarily worsen complications for patients with both COVID-19 and cancer.
This data is being presented by Layne Weatherford, PhD, UC postdoctoral fellow, at the American Association for Cancer Research Virtual Meeting: COVID-19 and Cancer, Monday, July 20.
Weatherford works in the lab of Trisha Wise-Draper, PhD, an associate professor of medicine, Division of Hematology Oncology, at the UC College of Medicine, UC Health oncologist and medical director of the UC Cancer Center Clinical Trials Office.